title: Experimental cytomorphological studies of the reaction of mononuclear phagocyte system in granulomatosis of mixed (silicotic and tuberculous) etiology.
abstract: Silicon dioxide in combination with Mycobacterium tuberculosis in BCG vaccine is characterized by a significantly higher granuloma-inducing activity than BCG or silicon dioxide alone. Cell "dissociation" from granulomas is not characteristic of granulomas induced by silicon dioxide or its combination with BCG (in contrast to BCG-induced granulomas). A steady increase in the counts and size, particularly on days 120-180, mainly at the expense of fibroblast accumulation and subtotal fibrosis, are intrinsic to these granulomas. Monocyte retention in the bone marrow is characteristic starting from day 56 until day 180 after injection of both granulomatous factors alone or in combination, particularly so in BCG granulomatosis.
authors.affiliation: Center of Clinical and Experimental Medicine, Siberian Division of Russian Academy of Medical Sciences, Novosibirsk, Russia.
authors.forename: V A
authors.initials: VA
authors.lastname: Shkurupy
authors.forename: A P
authors.initials: AP
authors.lastname: Nadeev
authors.forename: M A
authors.initials: MA
authors.lastname: Karpov
authors.forename: Yu S
authors.initials: YS
authors.lastname: Bugrimova
mesh_terms: D000818:Animals; D001500:BCG Vaccine; D006099:Granuloma / Q000209:etiology / Q000276:immunology*; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D012157:Mononuclear Phagocyte System / Q000276:immunology*; D012829:Silicosis / Q000276:immunology; D012830:Silicotuberculosis / Q000276:immunology* / Q000473:pathology
chemical_list: D001500:BCG Vaccine